Assessing and Treating Patients With Neuropathic Pain

Paul M. Scholten*, R. Norman Harden

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

9 Scopus citations

Abstract

Neuropathic pain (NP) is a significant source of suffering, disability, and impairment, as well as an enormous cost to society. Historically, pharmacologic treatment has been limited to drugs approved for other conditions, including anticonvulsants, antidepressants, antiarrhythmics, and opioids, but in the past 2 decades several drugs have been approved by the Food and Drug Administration specifically for NP. Understanding the underlying pathophysiology and clinical presentation of the various causes of NP states facilitates a rational selection of pharmacologic, interventional, rehabilitative, and psychological options for reducing pain and maximizing function.

Original languageEnglish (US)
Pages (from-to)S257-S269
JournalPM and R
Volume7
Issue number11
DOIs
StatePublished - Nov 1 2015

ASJC Scopus subject areas

  • Physical Therapy, Sports Therapy and Rehabilitation
  • Rehabilitation
  • Neurology
  • Clinical Neurology

Fingerprint Dive into the research topics of 'Assessing and Treating Patients With Neuropathic Pain'. Together they form a unique fingerprint.

Cite this